Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 13719 publications
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players US$ 2,995.00

Summary GlobalData has released its pharma report, “PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players”. The report is a vital ... with in-depth analysis on the companies in the rapidly growing Prophylactic hepatitis B virus vaccines Market. The report identifies and analyses the ...

Jan, 2014 70 pages
PharmaPoint: Migraine - Current and Future Players US$ 2,995.00

Summary GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies ...

Mar, 2014 54 pages
PharmaPoint: Crohn’s Disease - Current and Future Players US$ 2,995.00

Summary GlobalData has released its pharma report, “PharmaPoint: Crohn’s Disease - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn’s Disease Market. The report identifies and analyses the key ...

Jan, 2014 48 pages
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia US$ 1,995.00

... specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia”. The report is an essential source of information and ... process, the regulatory agencies and the approval processes for new drugs and medical devices Detailed analysis of the political and ...

Apr, 2014 205 pages
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

Summary During the forecast period from 2012–2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. ...

Feb, 2014 328 pages
PharmaPoint: Schizophrenia - Current and Future Players US$ 2,995.00

Summary GlobalData has released its pharma report, “PharmaPoint: Schizophrenia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Schizophrenia Market. The report identifies and analyses the key companies ...

Feb, 2014 40 pages
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected ... of key events as well the drivers and restraints affecting the US Migraine market. Reasons to buy Understand and capitalize by identifying products that ...

Mar, 2014 143 pages
PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023 US$ 4,995.00

... needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile. ... impact of key events as well the drivers and restraints affecting the Japan Migraine market. Reasons to buy Understand and capitalize by identifying products ...

Mar, 2014 114 pages
PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023 US$ 6,995.00

... 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to ... as well as a SWOT analysis. Sales forecast for the top drugs in 5EU (the UK, France, Italy, Spain, Germany) from 2012-2023. Analysis of the impact ...

Mar, 2014 149 pages
Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Clinical Trials Review, H1, 2014' provides data on the Refractory Multiple Myeloma clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Apr, 2014 166 pages
Refractory Leukemia Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Refractory Leukemia clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Apr, 2014 82 pages
Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... elemental information and data relating to the clinical trials on Refractory Chronic Lymphocytic Leukemia (CLL). It includes an overview of the trial numbers and their ... number of trials for the key drugs for treating Refractory Chronic Lymphocytic Leukemia (CLL). This report is built using data and information ...

Apr, 2014 198 pages
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Global Clinical Trials Review, H1, 2014' provides data on the Refractory Acute Myeloid Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Acute Myeloid Leukemia. It includes an overview of the trial numbers and their recruitment ...

Apr, 2014 120 pages
Recurrent Medulloblastoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Recurrent Medulloblastoma clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe ...

Mar, 2014 118 pages
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Clinical Trials Review, H1, 2014' provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Apr, 2014 181 pages
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... elemental information and data relating to the clinical trials on Recurrent Glioblastoma Multiforme (GBM). It includes an overview of the trial numbers and their recruitment ... number of trials for the key drugs for treating Recurrent Glioblastoma Multiforme (GBM). This report is built using data and information ...

Apr, 2014 155 pages
Pheochromocytoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

Summary GlobalData's clinical trial report, “Pheochromocytoma Global Clinical Trials Review, H1, 2014' provides data on the Pheochromocytoma clinical trial scenario. This ... by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs ...

Mar, 2014 82 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... information and data relating to the clinical trials on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). It includes an overview of the trial numbers and their ... number of trials for the key drugs for treating Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). This report is built using data and information ...

Apr, 2014 152 pages
Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Global Clinical Trials Review, H1, 2014' provides data on the Papillary Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Papillary Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment ...

Mar, 2014 284 pages
Oral Mucositis Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Oral Mucositis clinical trial scenario. This report provides elemental information and data relating to the ... relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Apr, 2014 88 pages
Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Clinical Trials Review, H1, 2014' provides data on the Opioid-Induced Constipation (OIC) clinical trial scenario. This report provides elemental information and ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Apr, 2014 141 pages
Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Global Clinical Trials Review, H1, 2014' provides data on the Opioid Induced Bowel Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid Induced Bowel Dysfunction. It includes an overview of the trial numbers and their recruitment ...

Apr, 2014 138 pages
Ocular Melanoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Ocular Melanoma clinical trial scenario. This report provides elemental information and data relating to the ... relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Mar, 2014 124 pages
Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Summary GlobalData's clinical trial report, “Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2014' provides data on the Non-Rhabdomyosarcoma clinical trial scenario ... for the key drugs for treating Non-Rhabdomyosarcoma. This report is built using data and information sourced from proprietary databases ...

Mar, 2014 115 pages
Neoplastic Syndrome Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Neoplastic Syndrome clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Apr, 2014 116 pages
Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Global Clinical Trials Review, H1, 2014' provides data on the Natural Killer Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Natural Killer Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status ...

Apr, 2014 71 pages
Mycosis Fungoides Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Mycosis Fungoides clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Apr, 2014 100 pages
Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Clinical Trials Review, H1, 2014' provides data on the Metastatic Uveal Melanoma clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Apr, 2014 95 pages
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Global Clinical Trials Review, H1, 2014' provides data on the Metastatic Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment ...

Apr, 2014 201 pages
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... ) Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the ...

Apr, 2014 177 pages
Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... information and data relating to the clinical trials on Metastatic Hepatocellular Carcinoma (HCC). It includes an overview of the trial numbers and their recruitment ... the number of trials for the key drugs for treating Metastatic Hepatocellular Carcinoma (HCC). This report is built using data and information ...

Apr, 2014 102 pages
Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Malignant Pleural Mesothelioma clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

Apr, 2014 145 pages
Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... elemental information and data relating to the clinical trials on Malignant Fibrous Histiocytoma Of Bone. It includes an overview of the trial numbers and their recruitment ... number of trials for the key drugs for treating Malignant Fibrous Histiocytoma Of Bone. This report is built using data and information ...

Mar, 2014 131 pages
Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Malignant Fibrous Histiocytoma clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

Mar, 2014 132 pages
Market Research Report on Global and Chinese Royal Jelly Oral Liquid Industry, 2009-2019 US$ 2,400.00

... of Royal Jelly Oral Liquid listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Royal Jelly Oral Liquid by calculation of main economic parameters of each company; ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Paracetamol Industry, 2009-2019 US$ 2,400.00

... The report further analyzes quantitatively 2009-2014 global and China’s total market of Paracetamol by calculation of main economic parameters of each company; The ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Paracetamol Industry. In the end, the report makes some ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus lactis Industry, 2009-2019 US$ 2,400.00

... product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus lactis by calculation of main economic parameters of each company; The breakdown data of Lactobacillus lactis market are presented by ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus Industry, 2009-2019 US$ 2,400.00

... report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus by calculation of main economic parameters of each company; The ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Lactobacillus Industry. In the end, the report makes some ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus helveticus Industry, 2009-2019 US$ 2,400.00

... specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus helveticus by calculation of main economic parameters of each company; The breakdown data of Lactobacillus helveticus market are presented by ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus casei Industry, 2009-2019 US$ 2,400.00

... manufacturers of Lactobacillus casei listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus casei by calculation of main economic parameters of each company; The ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus bulgaricus Industry, 2009-2019 US$ 2,400.00

... specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus bulgaricus by calculation of main economic parameters of each company; The breakdown data of Lactobacillus bulgaricus market are presented by ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Lactobacillus brevis Industry, 2009-2019 US$ 2,400.00

... product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Lactobacillus brevis by calculation of main economic parameters of each company; The breakdown data of Lactobacillus brevis market are presented by ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Famciclovir Industry, 2009-2019 US$ 2,400.00

... The report further analyzes quantitatively 2009-2014 global and China’s total market of Famciclovir by calculation of main economic parameters of each company; The ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Famciclovir Industry. In the end, the report makes some ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Anisole Industry, 2009-2019 US$ 2,400.00

... China’s top manufacturers of Anisole listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Anisole by calculation of main economic parameters of each company; The breakdown data ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Anisidine (Methoxyaniline) Industry, 2009-2019 US$ 2,400.00

... specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Anisidine (Methoxyaniline) by calculation of main economic parameters of each company; The breakdown data of Anisidine (Methoxyaniline) market are presented ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Adefovir Industry, 2009-2019 US$ 2,400.00

... ’s top manufacturers of Adefovir listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China’s total market of Adefovir by calculation of main economic parameters of each company; The breakdown data of ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Acyclovir Industry, 2009-2019 US$ 2,400.00

... and Chinese Acyclovir Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Acyclovir industry. The report firstly ... report further analyzes quantitatively 2009-2014 global and China’s total market of Acyclovir by calculation of main economic parameters of each company; The ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Dextrose Powder Industry, 2009-2019 US$ 2,400.00

... Chinese Dextrose Powder Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Dextrose Powder industry. The report ... report further analyzes quantitatively 2009-2014 global and China’s total market of Dextrose Powder by calculation of main economic parameters of each company; ...

Apr, 2014 150 pages
Market Research Report on Global and Chinese Insulin (API & Injection) Industry, 2009-2019 US$ 2,400.00

... report further analyzes quantitatively 2009-2014 global and China’s total market of Insulin (API & Injection) by calculation of main economic parameters of each ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Insulin (API & Injection) Industry. In the end, the report ...

Apr, 2014 150 pages
Hepatitis Drugs Markets in China US$ 4,000.00

China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and ...

Apr, 2014 170 pages
1 2 3 4 5 >
Skip to top